You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NIS793, spartalizumab, gemcitabine, nab-paclitaxel, mPDAC, TGFβ, PD-1, Phase II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Fayetteville, Arkansas
  • +122 more
Jan 27, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Pancreatic Cancer Trial in China (AK104, Gemcitabine, Nab-Paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +6 more
May 5, 2023

Melanoma, Pancreatic Ductal Adenocarcinoma Trial in Richmond (YH003, Toripalimab, Nab-paclitaxel)

Recruiting
  • Melanoma
  • Pancreatic Ductal Adenocarcinoma
  • Richmond, Victoria, Australia
    Epworth Medical Centre
Dec 22, 2021

Advanced Solid Tumors Trial in Nedlands (YH003, Toripalimab, Nab-paclitaxel)

Active, not recruiting
  • Advanced Solid Tumors
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Dec 29, 2021

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,

Active, not recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Pancreatic Cancer Trial in Beijing (Manganese Chloride, nab-paclitaxel, Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • Manganese Chloride
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Dec 20, 2020

Metastatic Pancreatic Cancer Trial in Shanghai (Camrelizumab, Nab paclitaxel, Gemcitabine Injection)

Unknown status
  • Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jul 31, 2020

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Soft Tissue Sarcoma Trial in Switzerland (Nab-Paclitaxel, gemcitabine)

Terminated
  • Soft Tissue Sarcoma
  • Basel, Switzerland
  • +7 more
Sep 27, 2022

Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

Recruiting
  • Phase II, Open-label, Parallel 2-arm, Multi-center
  • Gemcitabine 1000 mg
  • +4 more
  • Kaohsiung, Taiwan
  • +2 more
Jun 12, 2022

Pancreas Cancer Trial (surufatinib + camrelizumab + nab-paclitaxel + S-1, nab-paclitaxel + gemcitabine)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • surufatinib + camrelizumab + nab-paclitaxel + S-1
  • nab-paclitaxel + gemcitabine
  • Beijing, China
    Chinese PLA General Hospital
Sep 26, 2022

Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma Trial in Germany (Romidepsin, Azacitidine,

Recruiting
  • Pancreas Cancer
  • +2 more
  • Essen, Germany
  • +8 more
May 17, 2022

Pancreatic Tumor Trial in Korea, Republic of, Taiwan, United States (Antroquinonol)

Active, not recruiting
  • Pancreatic Neoplasm
  • Tampa, Florida
  • +8 more
Aug 16, 2022

Unresectable Locally Advanced or Metastatic Pancreatic Cancer Trial in Shanghai (surufatinib, KN046, gemcitabine)

Not yet recruiting
  • Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 16, 2023

Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,

Not yet recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 18, 2022

Pancreatic Cancer Non-resectable Trial in Worldwide (Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX,

Active, not recruiting
  • Pancreatic Cancer Non-resectable
  • Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
  • Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX
  • Phoenix, Arizona
  • +89 more
Dec 22, 2022

Pancreatic Cancer Trial in Nagoya (Am80)

Recruiting
  • Pancreatic Cancer
  • Nagoya, Aich, Japan
    Nagoya University Hospital
Sep 27, 2022

Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

Not yet recruiting
  • Locally Advanced Cholangiocarcinoma
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      CHA Bundang Medical Center
    Jan 24, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Relacorilant, 100 mg and 25 mg, Nab paclitaxel)

    Terminated
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Relacorilant, 100 mg and 25 mg
    • Nab paclitaxel
    • Scottsdale, Arizona
    • +17 more
    May 11, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in United

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Orange, California
    • +15 more
    Aug 23, 2022

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023